Literature DB >> 1864605

Sister chromatid exchanges are preferentially induced at expressed and nonexpressed common fragile sites.

B Hirsch1.   

Abstract

To investigate the relationship between common fragile sites and sister chromatid exchange (SCE), lymphocyte cultures were treated with aphidicolin and bromodeoxyuridine (BrdU) and analyzed using a sequential G----SCE staining protocol. A total of 1,163 SCEs were mapped to their corresponding G-band sites, which were assigned to one of the following four categories: fragile sites expressed; fragile sites nonexpressed; nonfragile sites with breaks; or nonfragile sites with no breaks. The designated common fragile sites were found to be preferred locations for SCE formation, not only when these sites were "expressed" as visible gaps or breaks, but even when they were "nonexpressed" in the cell. SCEs were also more likely to occur at nonfragile sites with breaks than at nonfragile with no break sites. Further, SCEs were found to be distributed nonrandomly across fragile sites and nonfragile sites, and among the fragile sites, the high frequency SCE sites were highly correlated with the high frequency breakage sites. These data support the hypothesis of common steps in the mechanism of aphidicolin-induced SCE formation and common fragile site expression.

Entities:  

Mesh:

Year:  1991        PMID: 1864605     DOI: 10.1007/bf00200908

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  8 in total

1.  The fragile site (16)(q22). II. Sister chromatid exchanges.

Authors:  M Schmid; W Feichtinger; T Haaf
Journal:  Hum Genet       Date:  1987-08       Impact factor: 4.132

2.  New Giemsa method for the differential staining of sister chromatids.

Authors:  P Perry; S Wolff
Journal:  Nature       Date:  1974-09-13       Impact factor: 49.962

3.  A simple G-banding technique.

Authors:  O Sanchez; J I Escobar; J J Yunis
Journal:  Lancet       Date:  1973-08-04       Impact factor: 79.321

4.  Synergistic effect of hydroxyurea and excessive thymidine on the expression of the common fragile sites at 3p14 and 16q23.

Authors:  Z A Yan; X Z Li; X T Zhou
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

5.  A replication model for sister-chromatid exchange.

Authors:  R B Painter
Journal:  Mutat Res       Date:  1980-05       Impact factor: 2.433

6.  Increased sister chromatid exchange frequency at Xq27 site in affected fragile X males.

Authors:  S L Wenger; J C Hennessey; M W Steele
Journal:  Am J Med Genet       Date:  1987-04

7.  Induction of sister chromatid exchanges at common fragile sites.

Authors:  T W Glover; C K Stein
Journal:  Am J Hum Genet       Date:  1987-11       Impact factor: 11.025

8.  Factors involved in differential Giemsa-staining of sister chromatids.

Authors:  K Goto; S Maeda; Y Kano; T Sugiyama
Journal:  Chromosoma       Date:  1978-05-16       Impact factor: 4.316

  8 in total
  5 in total

1.  Sources and structures of mitotic crossovers that arise when BLM helicase is absent in Drosophila.

Authors:  Matthew C LaFave; Sabrina L Andersen; Eric P Stoffregen; Julie K Holsclaw; Kathryn P Kohl; Lewis J Overton; Jeff Sekelsky
Journal:  Genetics       Date:  2013-10-30       Impact factor: 4.562

2.  The enigma of common fragile sites.

Authors:  I Simonic; G S Gericke
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

3.  Genetic and molecular analysis of familial isolated growth hormone deficiency.

Authors:  R Ruiz-Pacheco; P Chatelain; P C Sizonenko; M Bost; P Garandau; C Sultan
Journal:  Hum Genet       Date:  1993-10-01       Impact factor: 4.132

4.  The role of BRCA1 in homologous recombination repair in response to replication stress: significance in tumorigenesis and cancer therapy.

Authors:  Junran Zhang
Journal:  Cell Biosci       Date:  2013-02-06       Impact factor: 7.133

Review 5.  Breaking the paradigm: early insights from mammalian DNA breakomes.

Authors:  Xanita Saayman; Fumiko Esashi
Journal:  FEBS J       Date:  2021-05-01       Impact factor: 5.622

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.